Dysadherin expression promotes the motility and survival of human breast cancer cells by AKT activation (Q39365972)

11 September 2017

title

Dysadherin expression promotes the motility and survival of human breast cancer cells by AKT activation (English)

1 reference

11 September 2017

Yoo-Kyung Lee

1

1 reference

11 September 2017

Su-Youn Lee

2

1 reference

11 September 2017

Jeong-Ran Park

3

1 reference

11 September 2017

Ran-Ju Kim

4

1 reference

11 September 2017

Soo-Rim Kim

5

1 reference

11 September 2017

Kyung-Jin Roh

6

1 reference

11 September 2017

Jeong-Seok Nam

7

1 reference

11 September 2017

publication date

16 May 2012

1 reference

11 September 2017

1 reference

11 September 2017

volume

103

1 reference

11 September 2017

issue

7

1 reference

11 September 2017

page(s)

1280-1289

1 reference

11 September 2017

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02302.X

The transcriptional repressor Snail promotes mammary tumor recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02302.X

Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulates E-cadherin and promotes metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02302.X

Dysadherin expression facilitates cell motility and metastatic potential of human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02302.X

Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02302.X

Dysadherin: a new player in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02302.X

Dysadherin can enhance tumorigenesis by conferring properties of stem-like cells to hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02302.X

NF-kB in development and progression of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02302.X

NF-kappaB and cancer: how intimate is this relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02302.X

Roles of AKT signal in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02302.X

Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02302.X

AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02302.X

Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02302.X

Metastasis and AKT activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02302.X

Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02302.X

Bone sialoprotein mediates the tumor cell-targeted prometastatic activity of transforming growth factor beta in a mouse model of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02302.X

Ras activation contributes to the maintenance and expansion of Sca-1pos cells in a mouse model of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02302.X

5-aza-2'-deoxycytidine restores the E-cadherin system in E-cadherin-silenced cancer cells and reduces cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02302.X

Inhibition of MMP-9 transcription and suppression of tumor metastasis by pyrrole-imidazole polyamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02302.X

Regulation of cancer cell motility through actin reorganization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02302.X

Epithelial-mesenchymal transitions: twist in development and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02302.X

Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02302.X

The p85 regulatory subunit controls sequential activation of phosphoinositide 3-kinase by Tyr kinases and Ras.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02302.X

Epithelial-mesenchymal transitions in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02302.X

Deciphering cellular states of innate tumor drug responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02302.X

NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02302.X

Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02302.X

Involvement of Ras activation in human breast cancer cell signaling, invasion, and anoikis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02302.X

Effect of MUC1 mucin, an anti-adhesion molecule, on tumor cell growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02302.X

Aberrant O-glycosylation inhibits stable expression of dysadherin, a carcinoma-associated antigen, and facilitates cell-cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02302.X

Multiple signal transduction pathways link Na+/K+-ATPase to growth-related genes in cardiac myocytes. The roles of Ras and mitogen-activated protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02302.X

Role of protein kinase C in the signal pathways that link Na+/K+-ATPase to ERK1/2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02302.X

Novel role for Na,K-ATPase in phosphatidylinositol 3-kinase signaling and suppression of cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02302.X

Akt activation by estrogen in estrogen receptor-negative breast cancer cells

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22494103

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Dysadherin overexpression in pancreatic ductal adenocarcinoma reflects tumor aggressiveness: relationship to e-cadherin expression

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22494103

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Targeting Akt in cancer therapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22494103

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1349-7006.2012.02302.X

1 reference

11 September 2017

1 reference